Business Context and Reporting Period
This Form 8-K was filed by eFoodSafety.com, Inc. (not Pharmacyte Biotech, Inc.) on December 11, 2006. The report details the finalization of legal proceedings against a former founder and officer, Clarence W. Karney, regarding misappropriation of funds and unauthorized contracts.
Key Financial Metrics
The filing does not provide standard financial metrics such as revenue, profit, cash flow, margins, or debt levels. The only specific financial figure disclosed relates to a legal judgment:
- Default Judgment Amount: $9,284,910.30 entered against Karney on September 29, 2006.
- Amount Satisfied via Stock Garnishment: $4,559,842.50.
Material Changes
The primary material change reported is a significant reduction in the company's outstanding share count due to the cancellation of shares held by the former officer to satisfy the legal judgment.
- Shares Cancelled: 30,192,500 shares (comprising 25,192,500 shares seized via garnishment and an additional 5,000,000 shares).
- Resulting Outstanding Shares: 150,921,980 shares.
- Legal Status: Appeals regarding the judgment were unsuccessful, and the judgment is now final.
Outlook, Risks, and Management Commentary
Management confirms the successful execution of the writ of garnishment and the subsequent cancellation of shares. The filing indicates the resolution of a long-standing litigation matter initiated in November 2004. No forward-looking guidance or new risk factors were disclosed in this specific report.
Investor Verification Checklist
- Verify the current total number of issued and outstanding shares (150,921,980) against recent trading volumes.
- Confirm the status of the remaining unsatisfied portion of the $9,284,910.30 judgment.
- Review the company's capitalization table to ensure the cancelled shares are no longer listed as outstanding.
- Note the discrepancy between the request metadata (Pharmacyte Biotech) and the actual filing registrant (eFoodSafety.com, Inc.).